Compare Danaher Corporation (DHR) vs Eni SpA (E) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Eni SpA — how do they compare? Danaher Corporation trades at $220.24 (market cap $152.87B), while Eni SpA trades at $56.07 (market cap $79.81B). The key difference: Danaher Corporation is the larger of the two by market cap, and Eni SpA pays the higher dividend (4.39%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Eni SpA for 53 Days on average.
| DHR | E | |
|---|---|---|
Market Cap | $152.87B | $79.81B |
Volume | 5,228,698 | 365,912 |
Sector | Health | Energy |
52-Week High | $242.05 | $57.61 |
52-Week Low | $161.91 | $34.03 |
Typical Hold Time | 69 Days | 53 Days |
Enterprise Value | $175.08B | $104.34B |
Dividend Yield | 0.74% | 4.39% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
Eni (E) trades at $56.09, up 3.95% on the day, with mixed technical signals showing bearish moving averages but oversold short-term RSI. Fundamentally, the company shows attractive valuation metrics with P/E of 12.87 and EV/EBITDA of 4.18, though revenue has declined from $132.5B in 2022 to $82.2B in 2025. Recent news highlights strategic initiatives including humanoid robotics partnerships and fuel discount programs.
The stock presents value opportunity with strong cash flow generation and dividend yield, but faces headwinds from declining revenue trends and recent earnings misses. Analyst consensus leans cautious with 62% hold ratings, suggesting patience required for operational turnaround despite attractive valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →
